Gaetano Crupi, president and general manager of BMS in Brazil, leverages his long-standing experience at the head of prestigious pharmaceutical companies’ affiliates to provide an insightful overview of the key success factors to consider in the Brazilian market. He also documents BMS’ commitment to being a frontrunner in the medical, access, and commercial areas and his vision to tirelessly partner with the country’s healthcare stakeholders and entrench BMS’ leadership in the biopharmaceutical area.
Based on your long-standing experience honed heading MNC affiliates both in Brazil and abroad, how would you describe the importance of Brazil in the global strategy of multinational companies?
"In Brazil, BMS displays a profile and a vision that is perfectly aligned with the global level."
